Evidence map›Paper›PMID 16061697›Full record

ArticleThe Journal of cell biology2005

The epidermal barrier function is dependent on the serine protease CAP1/Prss8.

Céline Leyvraz, Roch-Philippe Charles, Isabelle Rubera, Marjorie Guitard, Samuel Rotman, Bernadette Breiden, Konrad Sandhoff, Edith Hummler

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in The Journal of cell biology, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01407471 (Interest of Topical Spironolactone's Administration to Prevent Corticoid-induced Epidermal Atrophy), which is not on this map. Cited by 135 papers.

0numbers the graph read from it
0cells of the map it votes in
135citing papers in PubMed
12.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01407471 phase2completednot on this mapstarted 2011, after this paper: background citation

Interest of Topical Spironolactone's Administration to Prevent Corticoid-induced Epidermal Atrophy

TypeinterventionalSponsorAssistance Publique - Hôpitaux de ParisRan2011 to 2012Enrolled26ConditionsCutaneous Atrophy Due to CorticosteroidsArmsClobetasol + Spironolactone, Clobetasol + Placebo, Placebo + Spironolactone, Placebo + Placebo
3 · Its place in the literature

Who cites it

135 citing papers in PubMed, 270 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Homology-based identification and structural analysis ofComputational and structural biotechnology journal · 2024
    Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Frontiers in molecular biosciences · 2023
    Article
  16. Resolution of Eczema with Multivalent Peptides.JID innovations : skin science from molecules to population health · 2022
    Article
  17. Article
  18. ENaC activation by proteases.Acta physiologica (Oxford, England) · 2022
    Review
  19. The Discovery and Function of Filaggrin.International journal of molecular sciences · 2022
    Review
  20. Article

75 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Céline LeyvrazDépartement de Pharmacologie et de Toxicologie, Université de Lausanne, CH-1005 Lausanne, Switzerland.
Roch-Philippe Charles
Isabelle Rubera
Marjorie Guitard
Samuel Rotman
Bernadette Breiden
Konrad Sandhoff
Edith Hummler
University of Lausanne · CHUniversity of Bonn · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Serine proteases are proteolytic enzymes that are involved in the regulation of various physiological processes. We generated mice lacking the membrane-anchored channel-activating serine protease (CAP) 1 (also termed protease serine S1 family member 8 [Prss8] and prostasin) in skin, and these mice died within 60 h after birth. They presented a lower body weight and exhibited severe malformation of the stratum corneum (SC). This aberrant skin development was accompanied by an impaired skin barrier function, as evidenced by dehydration and skin permeability assay and transepidermal water loss measurements leading to rapid, fatal dehydration. Analysis of differentiation markers revealed no major alterations in CAP1/Prss8-deficient skin even though the epidermal deficiency of CAP1/Prss8 expression disturbs SC lipid composition, corneocyte morphogenesis, and the processing of profilaggrin. The examination of tight junction proteins revealed an absence of occludin, which did not prevent the diffusion of subcutaneously injected tracer (approximately 600 D) toward the skin surface. This study shows that CAP1/Prss8 expression in the epidermis is crucial for the epidermal permeability barrier and is, thereby, indispensable for postnatal survival.

Indexed as

AnimalsCell DifferentiationDehydrationEpidermisFilaggrin ProteinsIntermediate Filament ProteinsLipid MetabolismMembrane ProteinsMiceMice, KnockoutOccludinPermeabilityProstasinSerine EndopeptidasesSkin AbnormalitiesTight JunctionsFilaggrin ProteinsIntermediate Filament ProteinsMembrane ProteinsOccludinOcln protein, mouseProstasinSerine Endopeptidases

Identifiers

PMID16061697
PMCPMC2171460
OpenAlexW2098964013

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.